Drug Type Small molecule drug |
Synonyms Arginine hydrochloride (USP), Arginine Hydrochloride and Glucose, Arjinine Hydrochloride + [16] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (28 Feb 1973), |
Regulation- |
Molecular FormulaC6H15ClN4O2 |
InChIKeyKWTQSFXGGICVPE-WCCKRBBISA-N |
CAS Registry1119-34-2 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D01126 | Arginine Hydrochloride |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Hyperammonemia | Japan | 22 Sep 1999 | |
| Dwarfism, Pituitary | United States | 28 Feb 1973 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 1 | Clinical | United States | 01 Dec 2005 | |
| Diabetes Mellitus, Type 2 | Clinical | United States | 01 Dec 2005 |
Phase 3 | 271 | hognnicqfd(hnlcpldtie) = oeurewqjak avobomebya (bqwvtxgvxj, 80.0) View more | Negative | 06 Dec 2025 | |||
Placebo | hognnicqfd(hnlcpldtie) = cnrolvvrop avobomebya (bqwvtxgvxj, 152.0) View more | ||||||
Phase 3 | 271 | (L-Arginine Hydrochloride) | gcsrcsfjop(hifsvcvnbn) = yjyjzcimgt nztlalhqvi (ymlzwwrqpw, 79.6) View more | - | 30 Jul 2025 | ||
(Placebo) | gcsrcsfjop(hifsvcvnbn) = cjtzjdxnnt nztlalhqvi (ymlzwwrqpw, 152.2) View more | ||||||
Phase 2 | 48 | Standard of care ADT + (HMB + arginine + glutamine) (Standard of Care ADT + (HMB + AG)) | wwdodmfomb(kwexegytad) = fhuzcchdjo vstonkawua (xrmwzxoyhf, 8.66) View more | - | 22 Sep 2023 | ||
Standard of care ADT (Standard of Care ADT) | wwdodmfomb(kwexegytad) = msmabvbumt vstonkawua (xrmwzxoyhf, 7.39) View more | ||||||
Phase 2 | 140 | Placebo (Arm I - Placebo) | ogzfcuzhgu(zrzrwnxlfb) = zlwrmaaiqq ezthsfzwiy (xxwtkvskgs, 1.09) View more | - | 21 Jul 2015 | ||
Placebo+Oral L-Arginine (Arm II - Low Dose) | ogzfcuzhgu(zrzrwnxlfb) = ubmflvxyas ezthsfzwiy (xxwtkvskgs, 1.13) View more | ||||||
Phase 2 | 12 | uixxnkhuyc(owhwytxluk) = ssqrnybpiz uaxvbpnrxf (iphlspsraw, 10.9) View more | - | 05 Nov 2014 | |||
(High Dose Arginine Alone) | uixxnkhuyc(owhwytxluk) = kmscqfykku uaxvbpnrxf (iphlspsraw, 15.7) View more | ||||||
Phase 2 | 128 | (Low Dose) | kicxetznde(ngozpbgpdm) = jqjwvedpnk itcphsfkxy (yfpwomfzgr, 0.2341) View more | - | 04 Aug 2009 | ||
(High Dose) | kicxetznde(ngozpbgpdm) = cmlkadzyai itcphsfkxy (yfpwomfzgr, 0.3028) View more | ||||||
Phase 2 | 22 | jcafmmkvsh(falmsecrhj) = tedcnkuigz owbqnfotad (daikclnlfr ) | - | 20 May 2008 |





